Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
|Market Price at 20-10-2017||$154.63|
|Price to Earnings Ratio||86.67|
|Market Capitalisation||$38,985.16 (million)|
|Return on Equity (ROE)||17.98%|